0 Комментарии
0 Поделились
874 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Oncology-Based Molecular Diagnostics Market Set to Hit USD 6.12 Billion by 2034, Fueled by Precision Medicine and Biomarker AdvancementsThe global oncology-based molecular diagnostics market is set for steady growth, with its valuation rising from USD 3.66 billion in 2024 to USD 6.12 billion by 2034, expanding at a CAGR of 5.3% over the forecast period (2025–2034). Increasing demand for personalized oncology testing, growing cancer prevalence, and rapid advancements...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Cancer/Tumor Profiling Market Size Projected to Reach USD 23.4 Billion by 2032“According to a new report published by Introspective Market Research, Cancer/Tumor Profiling Market by Technology, Cancer Type, and Application, The Global Cancer/Tumor Profiling Market Size Was Valued at USD 11.08 Billion in 2024 and is Projected to Reach USD 23.4 Billion by 2032, Growing at a CAGR of 9.8%.” Cancer/Tumor Profiling refers to the comprehensive molecular examination...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Carcinoembryonic Antigen Market to Reach USD 3.16 Billion by 2033, Growing at 5.06% CAGRMarket Overview The global carcinoembryonic antigen market size was valued at USD 2.03 billion in 2024 And is projected to reach from USD 2.13 billion in 2025 to USD 3.16 billion by 2033, growing at a CAGR of 5.06% during the forecast period (2024–2032). The global Carcinoembryonic Antigen market continues to evolve rapidly, driven...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Clinical Next-Generation Sequencing Testing Market Advances Precision Medicine ApplicationsExecutive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share Forecast The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period By considering a definite base year...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Colorectal Cancer Treatment Market Advances with Targeted Therapies"Executive Summary Colorectal Cancer Treatment Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Research and analysis about the key...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Colorectal Cancer Treatment Market Progresses with Advances in Targeted and ImmunotherapiesRegional Overview of Executive Summary Colorectal Cancer Treatment Market by Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. Colorectal Cancer Treatment Market analysis gives a clear idea on various segments...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Could the Tumor Markers Testing Market Revolutionize Early Cancer Detection?Executive Summary Tumor Markers Testing Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The market was valued at USD 16.7 billion in 2022 and would grow to USD 30.23 billion by 2030...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Cancer Diagnostics Market to Reach USD 178.26 Billion by 2033, Driven by Rising Screening DemandMarket Overview The global cancer diagnostics market size was valued at USD 106.32 billion in 2024 and is projected to reach from USD 112.60 billion in 2025 to USD 178.26 billion by 2033, growing at a CAGR of 5.91% during the forecast period (2025-2033). The global Cancer Diagnostics market continues to evolve rapidly, driven by shifting consumer trends,...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Global Clinical NGS Testing Market Surges with Precision Medicine Growth and Faster Genetic DiagnosticsDetailed Analysis of Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period With this Clinical...0 Комментарии 0 Поделились 507 Просмотры 0 предпросмотр
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations in the...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How Is Tumor Markers Testing Market Improving Early Cancer Detection Accuracy?IntroductionThe tumor markers testing market focuses on diagnostic tests that detect specific substances produced by cancer cells or by the body in response to cancer. These substances, known as tumor markers, are found in blood, urine, or tissue samples. Tumor marker tests support cancer detection, diagnosis, prognosis, treatment monitoring, and recurrence assessment. Cancer remains...0 Комментарии 0 Поделились 840 Просмотры 0 предпросмотр
-
How the Prostate Cancer Diagnostics Market Is Advancing with AI and Biomarker-Based Screening?Executive Summary Prostate Cancer Diagnostics Market: Growth Trends and Share Breakdown CAGR Value The global prostate cancer diagnostics market size was valued at USD 4.63 billion in 2024 and is expected to reach USD 10.31 billion by 2032, at a CAGR of 10.50% during the forecast period Prostate Cancer Diagnostics Market research report is a verified source of data and information that...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek